Tectonic Therapeutic logo

Tectonic Therapeutic Funding & Investors

Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.

tectonictx.com

Total Amount Raised: $80,000,000

Tectonic Therapeutic Funding Rounds

  • Series A

    $80,000,000

    Series A Investors

    Polaris Partners
    Timothy Springer
    Vida Ventures
    EcoR1 Capital
Funding info provided by Diffbot.